2-Amino-8-((2-fluorobenzyl)thio)-1,9-dihydro-6H-purin-6-one

ID: ALA3359162

Chembl Id: CHEMBL3359162

PubChem CID: 135567097

Max Phase: Preclinical

Molecular Formula: C12H10FN5OS

Molecular Weight: 291.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc2[nH]c(SCc3ccccc3F)nc2c(=O)[nH]1

Standard InChI:  InChI=1S/C12H10FN5OS/c13-7-4-2-1-3-6(7)5-20-12-15-8-9(17-12)16-11(14)18-10(8)19/h1-4H,5H2,(H4,14,15,16,17,18,19)

Standard InChI Key:  DBXBVKPIQPXRBY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3359162

    ---

Associated Targets(non-human)

folK 2-amino-4-hydroxy-6-hydroxymethyldihydropteridin e pyrophosphokinase (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folP Bacterial dihydropteroate synthase (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 291.31Molecular Weight (Monoisotopic): 291.0590AlogP: 1.66#Rotatable Bonds: 3
Polar Surface Area: 100.45Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.72CX Basic pKa: CX LogP: 1.93CX LogD: 1.78
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.64Np Likeness Score: -1.67

References

1. Dennis ML, Chhabra S, Wang ZC, Debono A, Dolezal O, Newman J, Pitcher NP, Rahmani R, Cleary B, Barlow N, Hattarki M, Graham B, Peat TS, Baell JB, Swarbrick JD..  (2014)  Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.,  57  (22): [PMID:25357262] [10.1021/jm501417f]
2. Dennis ML, Pitcher NP, Lee MD, DeBono AJ, Wang ZC, Harjani JR, Rahmani R, Cleary B, Peat TS, Baell JB, Swarbrick JD..  (2016)  Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli.,  59  (11): [PMID:27094768] [10.1021/acs.jmedchem.6b00002]
3. Müller R, Gerwel TM, Kimuda MP, Bishop ÖT, Veale CGL, Hoppe HC..  (2021)  Virtual screening and in vitro validation identifies the first reported inhibitors of Salmonella enterica HPPK.,  12  (10.0): [PMID:34778775] [10.1039/D1MD00237F]

Source